Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Examining the Effects of Ketamine Treatment on Synaptic Plasticity in Depression Using PET Imaging

NCT04091971 is registered in ClinicalTrials.gov with New York State Psychiatric Institute as lead sponsor.

NCT NCT04091971
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04091971 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Examining the Effects of Ketamine Treatment on Synaptic Plasticity in Depression Using PET Imaging
Lead sponsor
New York State Psychiatric Institute
Phase
Phase 4
Overall status
Completed
Start date
October 9, 2020
Completion date
May 1, 2022
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder